Therapeutic Effect of Intranasal Insulin on Cognition, Function, and AD Biomarker

Grants and Contracts Details


The goal of this trial is to examine the therapeutic effects of intranasally-administered insulin (INI) on cognition, entorhinal cortex and hippocampal atrophy, and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment (aMCI) or mild Alzheimer's disease (AD).
Effective start/end date3/1/134/30/16


  • University of California San Diego Health: $19,500.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.